Rising obesity is a worldwide problem, but it's happening particularly rapidly in China, outpacing even wealthy nations. "Close to 70 per cent of the US population are overweight. But soon China ...

A new study reveals the rising burden of liver cancer, highlighting the significant impact of metabolic risk factors like ...

As the year gets underway, analysts and biotech executives highlight cell therapy’s pivot from oncology to autoimmune ...

More than 180 million people live with obesity in China, which has a population of 1.4 billion. According to Chinese business news website Yicai, a dose of four Wegovy injections will cost 1,400 ...

New recommendations on how to define obesity would reduce the emphasis on body mass index and also take into account health ...

This three-part series from BioWorld highlights the strengths and weaknesses of major players in China’s obesity and diabetes market, including the pressing line of Chinese semaglutide biosimilars, ...

A new weight loss biotech launched with $410 million and three assets from China. Roche's Chugai penned a deal to develop ...

Data from Hengrui’s Phase II trial for its GLP-1/GIP product demonstrated a statistically significant mean weight loss of ...